Does Cannabis Intake Protect Against Non-alcoholic Fatty Liver Disease? A Two-Sample Mendelian Randomization Study
Background and AimNon-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. Previous observational studies suggested that cannabis use may be associated with a lower risk for NAFLD but the causal relationship remains unclear. We aim in this study to examine the causal effec...
Main Authors: | Xiaokun Wang, Zhipeng Liu, Wanqing Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2020.00949/full |
Similar Items
-
Association Between Psoriasis and Non-Alcoholic Fatty Liver Disease: A Two-Sample Mendelian Randomization Study
by: Li H, et al.
Published: (2023-11-01) -
Associations between simultaneous use of alcohol and cannabis and cannabis-related problems in 2014–2016: evidence from the Washington panel survey
by: Yachen Zhu, et al.
Published: (2024-02-01) -
Association of cannabis use disorder with cardiovascular diseases: A two-sample Mendelian randomization study
by: Miao Chen, et al.
Published: (2022-10-01) -
Serum 25-hydroxyvitamin D levels and the risk of non-alcoholic fatty liver: A two-sample Mendelian randomization study
by: Qi Sheng, et al.
Published: (2023-01-01) -
Cannabis Use and CKD: Epidemiological Associations and Mendelian RandomizationPlain-Language Summary
by: Sergio Dellepiane, et al.
Published: (2023-02-01)